Press release -
D-MARK Biosciences appointed as distributor in Canada
Halo Genomics has appointed D-MARK Biosciences as distributor in Canada. Under the term of the agreement, D-MARK Biosciences will market and support Halo Genomics’ proprietary technologies for next generation sequencing sample preparation.
D-MARK Biosciences provides advanced solutions for Genomics, Molecular Diagnostics, and Sequencing workflows, designed to provide faster and more accurate results that other technologies. The company was founded in 2008 and specializes in products associated with Next Generation Sequencing, PCR/qPCR, and Sanger Sequencing.
Mats Bergström, VP of Sales at Halo Genomics commented: "D-MARK Biosciences is an ideal partner for Halo Genomics with in-depth understanding of the Canadian market as well as an excellent team of sales, applications and support staff. We look forward to the continued growth and support of our customer base in Canada.”
”We are delighted to be working with Halo Genomics,” said Duane Mendis, General Manager of D-MARK Biosciences. “The HaloPlex™ PCR and Selector products fit perfectly with our current product portfolio. I look forward to serving Halo’s existing and future customers."
Learn more about D-MARK Biosciences at http://www.d-markbio.com/.
Related links
Topics
- Science, technology
Categories
- biotechnology
- next generation sequencing (ngs).
- sample preparation
- targeted resequencing
- ngs sample preparation
- target enrichment
Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.
